Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients.
Yong-Qiang BaoTeng-Hua YuWei HuangQing-Feng MaoGan-Jie TuBin LiAn YiJin-Gao LiJun RaoHuai-Wen ZhangChun-Ling JiangPublished in: Breast cancer (Tokyo, Japan) (2024)
SIB-IMRT after breast-conserving surgery in breast cancer patients demonstrated excellent clinical efficacy, mild acute and late toxicities, and satisfactory cosmetic outcomes in our study. SIB-IMRT appears to be a feasible and effective option for breast cancer patients suitable for breast-conserving surgery.
Keyphrases
- minimally invasive
- coronary artery bypass
- neoadjuvant chemotherapy
- surgical site infection
- early stage
- early breast cancer
- liver failure
- percutaneous coronary intervention
- squamous cell carcinoma
- drug induced
- coronary artery disease
- adipose tissue
- acute coronary syndrome
- respiratory failure
- insulin resistance
- aortic dissection
- acute respiratory distress syndrome
- glycemic control
- extracorporeal membrane oxygenation